In summary, the natural compound trigonelline has been shown to suppress Nrf2–ARE signaling and enhance the efficacy of ferroptosis inducers such as artesunate and GPX4 inhibitors in cisplatin-resistant HNC cells [27,28], highlighting its potential as a tumor-selective Nrf2 antagonist. This evidence concerns the gene NFE2L2 and neoplasm.